08.19.26 -- How To Prevent Particulate Contamination In Cell Therapies

Automated fill-finish systems protect sensitive cell therapies using low-shear handling to maintain dose uniformity, cell viability, and process consistency across every batch.

As complex therapies continue to evolve, advanced lyophilization approaches can help improve stability, consistency, scalability, and product quality.

Review strategies to assess the potential for human immune response following the administration of an mRNA therapeutic, the associated LNP, and the protein encoded for by the mRNA.

Pre-filled syringes offer operational benefits for delivering biologics and vaccines, with surging market demand highlighting the strategic value of partnering with a flexible CDMO.    

Denaturing and native analytical techniques expose molecular weight impurities in mAbs, creating a comprehensive purity profile to support confident manufacturing decisions.    

Novel CH1 binding resin technology addresses purification bottlenecks for Fab fragments and bispecific antibodies while simplifying downstream operations for sustainable manufacturing.

See how downstream steps can be linked into a coordinated workflow, with practical insight into automation, equipment integration, and process control for building a more efficient strategy.

Uncover how integrated approaches and process simplification can reduce bottlenecks, improve consistency, and support high-quality manufacturing outcomes across increasingly challenging pipelines.

This protein capture device demonstration showcases a cycling protocol that uses fast loading and non-loading residence times as well as a rapid CIP out to 100 cycles.